- Home
- NVR vs BNTX Comparison
NVR vs BNTX Comparison
Compare NVR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVR
- BNTX
- Stock Information
- Founded
- NVR 1980
- BNTX 2008
- Country
- NVR United States
- BNTX Germany
- Employees
- NVR N/A
- BNTX N/A
- Industry
- NVR Homebuilding
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVR Consumer Discretionary
- BNTX Health Care
- Exchange
- NVR Nasdaq
- BNTX Nasdaq
- Market Cap
- NVR 21.1B
- BNTX 25.0B
- IPO Year
- NVR N/A
- BNTX 2019
- Fundamental
- Price
- NVR $7,614.98
- BNTX $109.95
- Analyst Decision
- NVR Buy
- BNTX Strong Buy
- Analyst Count
- NVR 4
- BNTX 18
- Target Price
- NVR $9,023.33
- BNTX $141.55
- AVG Volume (30 Days)
- NVR 23.1K
- BNTX 771.1K
- Earning Date
- NVR 07-22-2025
- BNTX 08-04-2025
- Dividend Yield
- NVR N/A
- BNTX N/A
- EPS Growth
- NVR 1.37
- BNTX N/A
- EPS
- NVR 486.51
- BNTX N/A
- Revenue
- NVR $10,742,590,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- NVR N/A
- BNTX N/A
- Revenue Next Year
- NVR $0.13
- BNTX $10.68
- P/E Ratio
- NVR $15.67
- BNTX N/A
- Revenue Growth
- NVR 9.09
- BNTX 0.61
- 52 Week Low
- NVR $6,562.85
- BNTX $76.53
- 52 Week High
- NVR $9,964.77
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- NVR 61.73
- BNTX 57.74
- Support Level
- NVR $7,138.20
- BNTX $105.35
- Resistance Level
- NVR $7,812.40
- BNTX $109.68
- Average True Range (ATR)
- NVR 189.92
- BNTX 2.56
- MACD
- NVR 55.65
- BNTX 0.05
- Stochastic Oscillator
- NVR 80.99
- BNTX 87.00
About NVR NVR Inc.
NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the Mid-Atlantic, North East, Mid-East, and South East.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.